ArticleBMC cancer2025

Efficacy and safety of selinexor-based regimens as first-line treatments for elderly patients with diffuse large B-cell lymphoma: a real-world study.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.